ijms-logo

Journal Browser

Journal Browser

Advanced Research on the Major Histocompatibility Complex (MHC): From Bench to Bedside

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: 31 October 2025 | Viewed by 42

Special Issue Editor


E-Mail Website1 Website2
Guest Editor
Department of Immunology, Universidad Complutense de Madrid, 28012 Madrid, Spain
Interests: HLA; MHC-G; immunology; population genetics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

It has been over 40 years since the human Major Histocompatibility Complex (MHC), also known as HLAs, was first studied in relation to disease. Today, many hypotheses about certain HLA alleles—linked particularly to autoimmune conditions, but also to other diseases—have been put forward. However, no firm pathogenesis has been established for such a linkage. In the meantime, the function of presenting antigenic peptides to the clonotypic T cell receptor of the immune cells, necessary for starting an adaptive immune response, was attributed to the MHC and thus to HLAs. In addition, nonclassical class I genes (HLA-G, -E, and –F) seem to modulate immune responses in humans.

But what is the relationship between these recognised functions of the MHC and the use of HLAs in choosing donors and recipients in transplantation in order to minimise rejection, and what links are there between the MHC, disease, and drug reactions? The answers to these questions are not clear, and only theoretical ones are available. In addition, in birds, some molecular anomalies have been found in canonical-presenting MHC molecules, without a straightforward molecular and evolutionary explanation. Perhaps more emphasis should be placed on studying the molecular evolution and function not of single but of multiple MHC allelic genes conjointly, in a single haplotype, including complement alleles. This will probably help to uncover direct, pathogenetic molecular and cellular mechanisms that explain the role of the MHC in the diseases it is linked to and allow for the improvement of transplantation outcomes with allelic MHC compatibility. These are the aims of this Special Issue of our journal.

Prof. Dr. Antonio Arnaiz-Villena
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • HLA
  • immunology
  • HLA genetics and pharmacogenetics
  • immune and other functions of the MHC
  • classical and nonclassical MHC class I HLA genes
  • HLA-G
  • HLA-E
  • HLA-F
  • MHC evolution
  • complement
  • autoimmunity
  • immunodeficiency
  • cancer
  • HIV

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop